At 100XBIO we strive to deliver 100x more data on antigen specificity of the T cells in the limited sample volume (blood, tumor, lymph nodes), and as the downstream -- confirming the cells' phenotype and cytokine expression. Looking for (1) early investments, (2) R&D partners, and (3) early academia, biotech and pharma clients. We are raising $1.25M of pre-seed investment, and raised $375K. Accredited investors: welcome!
| Website | https://www.100xbio.com/ |
| Employees | 2 (2 on RocketReach) |
| Founded | 2023 |
| Address | 299 Washington St, Woburn, Massachusetts 01801, US |
| Phone | +1 267-240-8968 |
| Industry | Biotechnology Research |
| Keywords | Immunotherapy Research, Immuno-Oncology, Immunology Research, Single Cell Analysis, Biomarker Discovery, Therapeutic Antibodies, Cancer Research, Flow Cytometry, Precision Medicine, Molecular Biology, Biotechnology, High Throughput Screening, Data Analysis, Cell Biology |
Looking for a particular 100XBIO employee's phone or email?
100XBIO Questions
Sergei Pull is the CEO of 100XBIO.
2 people are employed at 100XBIO.
100XBIO is based in Woburn, Massachusetts.
Top 100XBIO Employees
-
Sergei Pull
CEO at 100XBIO
Cambridge, MA, US31 -
Timofei Bondarev
Co-Founder, CTO at 100XBIO
Arlington, MA, US31
G2Crowd Trusted
300K+
Plugin Users
